A balancing act in the United States Drug Industry: pioneer and generic drugs, the Orange Book, marketing protection and the US consumer

Mary Ann Holovac

World Patent Information, 2004, vol. 26, issue 2, 123-129

Abstract: This article reviews the range of laws and requirements that surround the creation, testing and marketing of pharmaceutical materials in the USA. It focuses in particular on the Orange Book--more formally Approved Drug Products with Therapeutic Equivalence Evaluations--and its role in the process of providing safe and effective drugs at reasonable cost for the consumer, while ensuring that the corresponding research and development in creating new drug products is rewarded. Specific topics covered include: the history and purpose of the 'Orange Book', the legislative background, safety and effectiveness, therapeutic equivalence, Waxman-Hatch legislation, the patent position, various forms of exclusivity of marketing rights--such as orphan, Waxman-Hatch, and pediatric, and patent certification as part of an abbreviated new drug application.

Keywords: Pharmaceutical; products; Orange; Book; Therapeutic; equivalence; Patent; protection; New; drug; application; NDA; Drug; safety; Drug; effectiveness; Generic; drug; Grandfather; drug; Orphan; drug; Pediatric; drug; Kefauver-Harris; Waxman-Hatch; Bioequivalence; Patent; certification; Marketing; exclusivity (search for similar items in EconPapers)
Date: 2004
References: Add references at CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S0172-2190(03)00179-0
Full text for ScienceDirect subscribers only

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:worpat:v:26:y:2004:i:2:p:123-129

Ordering information: This journal article can be ordered from
http://www.elsevier.com/wps/find/supportfaq.cws_home/regional
http://www.elsevier. ... _01_ooc_1&version=01

Access Statistics for this article

World Patent Information is currently edited by Michael Blackman

More articles in World Patent Information from Elsevier
Bibliographic data for series maintained by Catherine Liu (repec@elsevier.com).